A hair loss drug that first gained popularity in the 1990s is seeing a resurgence of interest. Minoxidil is best known as the ...
The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...
The future of American drug innovation is threatened by US regulations that permit knockoff versions of new drugs to be sold to US consumers.
The explosion of GLP-1 weight loss drugs is reminiscent of the early days of PD-1 inhibitors, but key market differences ...
The United States has led the world in pharmaceutical innovation for decades by developing drugs that combat cancer, heart ...
August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new ...
The Food and Drug Administration (FDA) has approved Iluvien® (fluocinolone acetonide intravitreal implant) for the treatment of chronic non-infectious ...
A Trump executive order forming the commission tasked them with assessing the ‘threat posed by’ ADHD meds. Learn how experts ...
Data from two studies suggest that a once-daily combination therapy of doravirine and islatravir was noninferior to current, ...
A rise in the use of non-FDA-approved diabetes and obesity medications has spurred health care professionals and medical ...
Colonel Jeffrey D. Glover and Dr. Benjamin F. Chavis Jr. The new FDA-approved weight loss medicines have changed the game for people with obesity, offering millions of Americans a chance to transform ...
My survival is based on research. With limited NIH funding, I fear that my life, and the lives of others, will be left ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback